What is glutamate dehydrogenase (GDH) testing for Clostridioides difficile?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is GDH for C. difficile?

GDH (glutamate dehydrogenase) is a highly sensitive screening test that detects a common metabolic enzyme present in all strains of Clostridioides difficile, but it cannot distinguish between toxigenic (disease-causing) and non-toxigenic strains, so it must always be followed by a confirmatory test for toxins. 1

How GDH Testing Works

GDH immunoassays detect a highly conserved metabolic enzyme (common antigen) that is present in high levels in all isolates of C. difficile—both toxigenic and non-toxigenic strains 1. This is the critical limitation: GDH lacks specificity because it detects the organism itself, not the toxins that actually cause disease 1.

Performance Characteristics

  • Sensitivity: High (>90%, with some studies showing 100%) 1, 2, 3
  • Specificity: Low 1
  • Negative Predictive Value: 100% 2—meaning a negative GDH test effectively rules out CDI
  • Positive Predictive Value: ~82% 2—meaning positive results require confirmation

Clinical Use in Diagnostic Algorithms

GDH serves as the initial screening step in 2- and 3-step diagnostic algorithms 1, 4. The IDSA/SHEA 2017 guidelines explicitly describe this approach:

Two-Step Algorithm:

  1. GDH screening (if negative → stop, CDI ruled out)
  2. If GDH positive → perform toxin EIA or NAAT for confirmation

Three-Step Algorithm:

  1. GDH screening (if negative → stop)
  2. If GDH positive → toxin A/B EIA
  3. If GDH positive but toxin negative → NAAT for final determination

This combination approach provides rapid results, improved sensitivity compared to toxin EIA alone, and can be economical 1.

Why GDH Cannot Be Used Alone

Since GDH is present in both toxigenic and non-toxigenic C. difficile strains, a positive GDH result could represent:

  • Active CDI (toxigenic strain producing toxins)
  • Asymptomatic colonization with a toxigenic strain
  • Colonization with a non-toxigenic strain

This is why confirmatory testing is mandatory—you need to determine if toxins or toxin genes are present 1, 5, 6.

Key Clinical Pitfall

The major advantage of GDH is its excellent negative predictive value: if GDH is negative, you can confidently rule out CDI and stop testing 2, 7. However, never treat based on a positive GDH alone without confirmatory testing, as approximately 18-20% of GDH-positive samples will be false positives (non-toxigenic strains or colonization) 2.

Practical Considerations

Specimen handling matters: freezing stool samples can negatively affect both GDH and toxin detection 8. Use fresh specimens whenever possible for optimal test performance.

The 2019 systematic review supports using testing algorithms that incorporate GDH as an effective screening method when combined with NAAT or toxin testing 4, and this remains a recommended ASM best practice for detecting C. difficile.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.